Zhenwen Zhao , Yulun Chen , Hui Liu , Haitian Tang , Minglei Teng , Xue Liu , Jianlin Ge , Shilong Shao , Zhenjie Li , Tao Jiang , Chao Liu , Xiao Xu , Gang Liu
{"title":"Amidoxime-based radio-microspheres for Internal Irradiation combined with a checkpoint-blocking nanobody boost antitumor immunity","authors":"Zhenwen Zhao , Yulun Chen , Hui Liu , Haitian Tang , Minglei Teng , Xue Liu , Jianlin Ge , Shilong Shao , Zhenjie Li , Tao Jiang , Chao Liu , Xiao Xu , Gang Liu","doi":"10.1016/j.nantod.2024.102383","DOIUrl":null,"url":null,"abstract":"<div><p>Trans-arterial radioembolization (TARE) therapy confronts significant technical challenges in the preparation of metal nuclide-labeled microsphere carriers, the development of stable and efficient radionuclide labeling strategies, and the ability to treat multiple small lesions in solid tumors. In this study, we synthesized <sup>177</sup>Lu-labeled amidoxime-based polyvinyl alcohol microspheres (<sup>177</sup>Lu-PVA-<em>g</em>-PAO-Ms) using in situ synthesis of trunk compounds with chem-induced grafting polymerization. The resulting <sup>177</sup>Lu-PVA-<em>g</em>-PAO-Ms showed excellent stability in radiolabeling and demonstrated high accumulation and prolonged retention in various preclinical rodent models, as observed through SPECT/CT imaging. The cumulative radioactivity uptake in the tumor reached as high as 12.27 %ID/g. In a mouse subcutaneous metastatic tumor model, we observed a significant abscopal effect of radioimmunotherapy after administering a combination of <sup>177</sup>Lu-PVA-<em>g</em>-PAO-Ms and an anti-PD-L1 nanobody. These findings highlight the ability of PVA-<em>g</em>-PAO-Ms to chelate radionuclides efficiently and securely. Furthermore, when combined with nanobodies with enhanced tissue penetration capabilities, these microspheres hold great potential as innovative carrier platforms, offering new therapeutic strategies for integrating TARE with systemic immunotherapy.</p></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":null,"pages":null},"PeriodicalIF":13.2000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nano Today","FirstCategoryId":"88","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1748013224002391","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Trans-arterial radioembolization (TARE) therapy confronts significant technical challenges in the preparation of metal nuclide-labeled microsphere carriers, the development of stable and efficient radionuclide labeling strategies, and the ability to treat multiple small lesions in solid tumors. In this study, we synthesized 177Lu-labeled amidoxime-based polyvinyl alcohol microspheres (177Lu-PVA-g-PAO-Ms) using in situ synthesis of trunk compounds with chem-induced grafting polymerization. The resulting 177Lu-PVA-g-PAO-Ms showed excellent stability in radiolabeling and demonstrated high accumulation and prolonged retention in various preclinical rodent models, as observed through SPECT/CT imaging. The cumulative radioactivity uptake in the tumor reached as high as 12.27 %ID/g. In a mouse subcutaneous metastatic tumor model, we observed a significant abscopal effect of radioimmunotherapy after administering a combination of 177Lu-PVA-g-PAO-Ms and an anti-PD-L1 nanobody. These findings highlight the ability of PVA-g-PAO-Ms to chelate radionuclides efficiently and securely. Furthermore, when combined with nanobodies with enhanced tissue penetration capabilities, these microspheres hold great potential as innovative carrier platforms, offering new therapeutic strategies for integrating TARE with systemic immunotherapy.
期刊介绍:
Nano Today is a journal dedicated to publishing influential and innovative work in the field of nanoscience and technology. It covers a wide range of subject areas including biomaterials, materials chemistry, materials science, chemistry, bioengineering, biochemistry, genetics and molecular biology, engineering, and nanotechnology. The journal considers articles that inform readers about the latest research, breakthroughs, and topical issues in these fields. It provides comprehensive coverage through a mixture of peer-reviewed articles, research news, and information on key developments. Nano Today is abstracted and indexed in Science Citation Index, Ei Compendex, Embase, Scopus, and INSPEC.